Pharmaceutical Industries Ltd.
Menu
Health Products
WCAG 2.0
Print

RAN-RISPERIDONE
« Back to list view

Product Information

  • DIN:
    02328305
  • Active Ingredients :
    risperidone
  • Innovator Name:
    Risperdal®
  • Category:
    Antipsychotic Agent
  • Dosage form:
    Tablet
  • Strength:
    0.25 mg
  • Package size:
    100 Bottle
  • UPC Code:
    876515000046
  • Non-medicinal ingredients :
    colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium lauryl sulphate, talc and titanium dioxide, iron oxide yellow
RAN-RISPERIDONE

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02328313
  • Active Ingredients :
    risperidone
  • Innovator Name:
    Risperdal®
  • Category:
    Antipsychotic Agent
  • Dosage form:
    Tablet
  • Strength:
    0.50 mg
  • Package size:
    100 Bottle
  • UPC Code:
    876515000060
  • Non-medicinal ingredients :
    colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium lauryl sulphate, talc and titanium dioxide, iron oxide red
RAN-RISPERIDONE

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02328321
  • Active Ingredients :
    risperidone
  • Innovator Name:
    Risperdal®
  • Category:
    Antipsychotic Agent
  • Dosage form:
    Tablet
  • Strength:
    1mg
  • Package size:
    60 Blister 500 Bottle
  • UPC Code:
    876515003108 876515000091
  • Non-medicinal ingredients :
    colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium lauryl sulphate, talc and titanium dioxide
RAN-RISPERIDONE

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02328348
  • Active Ingredients :
    risperidone
  • Innovator Name:
    Risperdal®
  • Category:
    Antipsychotic Agent
  • Dosage form:
    Tablet
  • Strength:
    2mg
  • Package size:
    60 Blister 500 Bottle
  • UPC Code:
    876515003115 876515000145
  • Non-medicinal ingredients :
    colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium lauryl sulphate, talc and titanium dioxide, FD & C Yellow #6 Aluminum Lake
RAN-RISPERIDONE

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02328364
  • Active Ingredients :
    risperidone
  • Innovator Name:
    Risperdal®
  • Category:
    Antipsychotic Agent
  • Dosage form:
    Tablet
  • Strength:
    3mg
  • Package size:
    60 Blister 250 Bottle
  • UPC Code:
    876515003122 876515000152
  • Non-medicinal ingredients :
    colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium lauryl sulphate, talc and titanium dioxide, D & C Yellow #10 Aluminum Lake
RAN-RISPERIDONE

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02328372
  • Active Ingredients :
    risperidone
  • Innovator Name:
    Risperdal®
  • Category:
    Lipid metabolism regulator
  • Dosage form:
    Tablet
  • Strength:
    4mg
  • Package size:
    100 Bottle
  • UPC Code:
    876515000169
  • Non-medicinal ingredients :
    colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium lauryl sulphate, talc and titanium dioxide, D & C Yellow #10 Aluminum Lake and FD & C Blue #2 Aluminum Lake
RAN-RISPERIDONE

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Health Products
WCAG 2.0

Copyright © Taro Pharmaceutical Industries Ltd.

Privacy Statement | Terms of Use | Safe Harbor Statement